Cost-Effectiveness Analysis of New Direct-Acting Antivirals (DAAs) therapy for patients with untreated Chronic Hepatitis C genot
Boston University
Health Sciences
635 Commonwealth Ave
Boston,
MA
USA
02215
Papers:
Cost-Effectiveness Analysis of New Direct-Acting Antivirals (DAAs) therapy for patients with untreated Chronic Hepatitis C genot
Boston University
Health Sciences
635 Commonwealth Ave
Boston,
MA
USA
02215